Health Awareness
CEO of Epilepsy Action Australia slams “appalling” TikTok ‘seizure challenge’ trend
CEO of Epilepsy Action Australia, Carol Ireland, released a public statement yesterday, following a recent controversial viral trend on the video app TikTok, known as the “seizure challenge”. Ms Ireland commented she is “appalled that people are pretending to have seizures as if it’s a joke”. The latest challenge to have gone viral on TikTok,…
Read MoreWhat’s in a name? Coining history’s deadliest pandemics
Here’s some scientific nomenclature to help kick-start your Monday! For centuries before the advent of coronavirus, many contagions, including the Bubonic Plague, syphilis, smallpox and tuberculosis, claimed the lives of hundreds of millions of people worldwide. Ironically, many of these contagions were awarded a ‘rainbow’ of names. Syphilis – a bacterial infection commonly spread by…
Read MoreAustralians urged to get their flu vaccination earlier than usual due to COVID-19
With the COVID-19 pandemic sweeping the nation, this year more than ever, the Federal Government and healthcare professionals are urging Australians to receive their flu shot as soon as possible. Vaccinating against the flu will reduce the risk of a very dangerous double-up of flu and coronavirus. In 2019, Australia witnessed a record flu season,…
Read MoreThe rise of telehealth
For a long time, access to healthcare has been an ongoing struggle for many rural and remote communities around Australia, with many facing long wait times, limited access to specialist services, and the need to travel long distances to major cities. Furthermore, office-workers and parents with young children often have difficulty finding time to attend…
Read MoreAussies & Kiwis with incurable blood cancer receive newly subsidised treatment option
Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…
Read More